Hansford Karl A, Reid Robert C, Clark Chris I, Tyndall Joel D A, Whitehouse Michael W, Guthrie Tom, McGeary Ross P, Schafer Karl, Martin Jennifer L, Fairlie David P
Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland Brisbane, Australia.
Chembiochem. 2003 Mar 3;4(2-3):181-5. doi: 10.1002/cbic.200390029.
Few reported inhibitors of secretory phospholipase A(2) enzymes truly inhibit the IIa human isoform (hnpsPLA(2)-IIa) noncovalently at submicromolar concentrations. Herein, the simple chiral precursor D-tyrosine was derivatised to give a series of potent new inhibitors of hnpsPLA(2)-IIa. A 2.2-A crystal structure shows an inhibitor bound in the active site of the enzyme, chelated to a Ca(2+) ion through carboxylate and amide oxygen atoms, H-bonded through an amide NH group to His48, with multiple hydrophobic contacts and a T-shaped aromatic-group-His6 interaction. Antiinflammatory activity is also demonstrated for two compounds administered orally to rats.
很少有已报道的分泌型磷脂酶A(2) 酶抑制剂能在亚微摩尔浓度下真正非共价地抑制人IIa亚型(hnpsPLA(2)-IIa)。在此,简单的手性前体D-酪氨酸经衍生化得到了一系列强效的hnpsPLA(2)-IIa新抑制剂。一个2.2埃的晶体结构显示一种抑制剂结合在该酶的活性位点,通过羧酸根和酰胺氧原子与一个Ca(2+)离子螯合,通过酰胺NH基团与His48形成氢键,有多个疏水接触以及一个T形芳基- His6相互作用。对口服给予大鼠的两种化合物也证明了其抗炎活性。